tradmap

OMDA Omada Health, Inc.

$17.86 -4.77%

Data as of close

Healthcare · Services-Health Services

Omada Health, Inc. (OMDA) is a healthcare company in the Services-Health Services industry, with a market capitalization of $1.1 billion. Shares last traded at $17.86, 31.6% below their 52-week high. Over the past year the stock is down 26.2%. OMDA trades at a price-to-earnings ratio of 253.97, above the Services-Health Services median of 96.60. Net profit margin is 1.4%, above the peer median of 0.5%. Revenue grew 53.2% year over year.

Market Cap
$1.1B
Shares Out
61.2M
EPS (TTM)
$1.07
P/E (TTM)*
253.97
P/S Ratio
3.53
P/B Ratio
4.33
Dividend / Share
—
Dividend Yield
—
52-Week High
$26.13
52-Week Low
$10.31
Volume (venue)
49,525
Avg Vol (3m, venue)
70,890.27

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-7.27%
1M
-12.32%
3M
-11.47%
6M
+13.61%
YTD
+13.15%
1Y
-26.20%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
38.90
SMA (50)
$20.64
SMA (200)
$17.71
Price vs SMA50
-13.48%
Price vs SMA200
+0.86%
ATR (14)
$1.13

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$310M
Net Income
$4M
Gross Margin
68.2%
Operating Margin
-0.1%
Net Margin
1.4%
Return on Equity
1.7%
Return on Assets
1.3%
Current Ratio
3.91
Debt / Equity
0.00
Revenue Growth (YoY)
+53.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.08 2026-08-07
Q1 2026 -$0.05 2026-05-08
Q4 2025 (derived) $1.10 2026-03-06
FY 2025 -$0.35 2026-03-06
Q3 2025 -$0.06 2025-11-07
Q2 2025 -$0.24 2025-08-08

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Health Services peers

OMDA vs 13 industry peers (Services-Health Services), by market cap. Data as of close

P/E vs peers
253.97 / 96.60 med
+163% premium
P/S vs peers
3.53 / 1.42 med
+148% premium
Net margin vs peers
1.4% / 0.5% med
above median
1–13 of 13
LFSTLifestance Health Group, Inc.$5.1B100.163.203.2%-1.08%
PRVAPrivia Health Group, Inc.$2.7B96.601.151.2%-0.98%
WGSGenedx Holdings Corp.$1.9B—4.21-23.4%-7.17%
PNTGPennant Group, Inc.$1.4B43.841.292.9%-2.73%
USPHU S Physical Therapy Inc /Nv$1.3B39.391.564.0%-0.65%
INNVInnovAge Holding Corp.$1.2B—1.23-0.3%-2.94%
OMDAOmada Health, Inc.$1.1B253.973.531.4%-4.77%
ALPSAlps Group Inc$53M———-2.14%
EUDAEUDA Health Holdings Ltd$30M—4.40-40.7%-9.52%
DCGODocGo Inc.$21M—0.07-65.3%-14.63%
PIIIP3 Health Partners Inc.$13M—0.01-10.1%-7.10%
ATPCAgape ATP Corp$1M———-12.67%
PIIIWP3 Health Partners Inc.————-16.00%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.